---

Synthesis and antimicrobial activities of some novel thieno [2,3-d]- Pyrimidin-4(3H)-One derivatives

Full Text PDF

---

Original Article

Author Details : D. P. Kawade, A.V. Hadke

Volume : 5, Issue : 2, Year : 2018

Article Page : 59-66

https://doi.org/10.18231/2394-2797.2018.0010

Suggest article by email

Get Permission

Abstract

Pain and inflammation are simultaneous responses in bacterial infections. In current clinical practice, the agents like antimicrobial drug are prescribed concurrently. A POCl₃ catalyzed, efficient, one-step and solvent-free synthesis of novel thieno [2, 3-d] pyrimidin-4(3H)-one derivatives from 2-amino-4,5-substitutedthiophene-3-carbonitrile has been developed using various aliphatic acid under conventional heating and microwave irradiation. The formation of compounds was confirmed using elemental analysis and spectroscopic techniques like FTIR, ¹H NMR and Mass spectroscopy. All synthesized compounds have been screened for their antimicrobial activity against Escherichia coli (Gram –ve strain), Bacillus subtilis (Gram +ve strain) for antibacterial activity and antifungal activities against Aspergillus niger and Candida albicans. The result showed that synthesized compounds exhibit weak, moderate and good antimicrobial activity. It was observed that the compounds 2a, 2c, 2d, 2e, 2f, 2g, 2j and 2k showed good antimicrobial activity whereas compounds 2b, 2i, 2j showed significant antimicrobial activity compared with standard drug Streptomycin and Amphotericin B respectively.

Keyword:POCl₃, Thieno[2, 3-d]pyrimidin-4 (3H)-one, Antimicrobial activity, Streptomycin and Amphotericin B

How to cite : Kawade D P, Hadke A, Synthesis and antimicrobial activities of some novel thieno [2,3-d]- Pyrimidin-4(3H)-One derivatives. Int J Pharm Chem Anal 2018;5(2):59-66

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.